ArticleCells2021

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2.

Roberta Rinaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.